Sign in

CIK 0000879169 · Large accelerated filer

INCYTE CORP

Sign in to watch
Ticker
INCY
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
943136539
Phone
3024986700
Business address
1801 AUGUSTINE CUT-OFF, WILMINGTON, DE, 19803
Former names
INCYTE INC, INCYTE GENOMICS INC, INCYTE PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$32,959,897
in 5 filings, $33.0M under 10b5-1 plans

Net −$32,959,897. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Stein Steven H −$28.4M CMO & Head of Late-Stage Dev. sold 89% of stake
  2. CAGNONI PABLO J −$4.5M President, Global Head of R&D sold 17% of stake
  3. Tray Thomas −$73K Principal Accounting Officer sold 3% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −2,284 2,938
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −2,709 1,233
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −3,148 0
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −2,072 2,665
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −9,459 0
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −2,623 0
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −2,864 191
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −1,643 0
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −3,023 202
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −2,623 0
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −1,642 0
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −2,293 0
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −85 2,207
2026-07-31 Mayes Patrick A EVP & Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) 10b5-1 −326 6,055
2026-07-31 CAGNONI PABLO J President, Global Head of R&D Sale 10b5-1 −15,888 $119.70 $1.9M 215,444
2026-07-23 Heeson Lee EVP, Head of Incyte Intl Grant or award · Employee Stock Option (right to buy) +15,423 15,423
2026-07-23 Heeson Lee EVP, Head of Incyte Intl Grant or award · Performance Shares +13,498 13,498
2026-07-23 Morrissey Michael James EVP, Head of Tech. Operations Grant or award · Employee Stock Option (right to buy) +6,426 6,426
2026-07-23 Morrissey Michael James EVP, Head of Tech. Operations Grant or award · Performance Shares +8,999 8,999
2026-07-16 Hoffman Richard A. EVP & General Counsel Grant or award +7,395 16,861

Page 6 of 15 · 293 trades